Can-Fite BioPharma (CANF) Net Margin Growth (1y) (2016 - 2023)
Can-Fite BioPharma (CANF) Net Margin Growth (1y) (2016 - 2023) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | -185.00 |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | -763.00 |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 529.00 |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 4,168.00 |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 673.00 |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 2,208.00 |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 29,636.00 |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | -392.00 |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | -1,652.00 |
| 10 | Can-Fite BioPharma | 2.82 Mn | -8.73 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | 291,933.00 |
| Sep 30, 2023 | 30,974.00 |
| Jun 30, 2023 | -39,193.00 |
| Mar 31, 2023 | -11,370.00 |
| Dec 31, 2022 | -1.80 Mn |
| Sep 30, 2022 | 415,466.00 |
| Jun 30, 2022 | -380,471.00 |
| Mar 31, 2022 | 8,160.00 |
| Dec 31, 2021 | -38,957.00 |
| Sep 30, 2021 | 428,786.00 |
| Jun 30, 2021 | -407,618.00 |
| Mar 31, 2021 | 92,401.00 |
| Dec 31, 2020 | 776,071.00 |
| Sep 30, 2020 | -995,969.00 |
| Jun 30, 2020 | 844,767.00 |
| Mar 31, 2020 | -271,868.00 |
| Dec 31, 2019 | -729,848.00 |
| Sep 30, 2019 | 24,917.00 |
| Jun 30, 2019 | -331,705.00 |
| Mar 31, 2019 | 79,806.00 |